Pruritus measurement and treatment

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 285-288

  Langner, M D ^a   Maibach, H I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CAPSAICIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYPROHEPTADINE; DIPHENHYDRAMINE; DOXEPIN; GAMMA LINOLENIC ACID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; PERMETHRIN; PRAMOCAINE; PROMETHAZINE;

ATOPIC DERMATITIS; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; HUMAN; MEASUREMENT; NEUROANATOMY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; SCABIES; SEDATION; SIDE EFFECT; SKIN RECEPTOR; TREATMENT INDICATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ANTIPRURITICS; HUMANS; PRURITUS; SEVERITY OF ILLNESS INDEX;

EID: 62449253870     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03218.x     Document Type: Review

References (30)

1. Yosipovitch G. How to treat that nasty itch. Exp Dermatol 2005 14 : 478 9.
2. Biro T, Ko MC, Bromm B et al. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol 2005 14 : 225 40.
3. Wahlgren CF. Measurement of itch. Semin Dermatol 1995 14 : 277 84.
4. Fleischer AB. The Clinical Management of Itching. New York : Parthenon Publications Group, 2000.
5. Majeski CJ, Johnson JA, Davison SN et al. Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol 2007 156 : 667 73.
6. Bartoshuk LM, Duffy VB, Green BG et al. Valid across-group comparisons with labeled scales: the gLMS versus magnitude matching. Physiol Behav 2004 82 : 109 14.
7. Chen YC, Chiu WT, Wu MS. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis 2006 48 : 69 76.
8. Yosipovitch G, Fast K, Bernhard JD. Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Invest Dermatol 2005 125 : 1268 72.
9. Yosipovitch G, Duque MI, Fast K et al. Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study. Br J Dermatol 2007 156 : 629 34.
10. Wahlgren CF. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991 165 : 1 53.
11. Wahlgren CF, Ekblom A, Hagermark O. Some aspects of the experimental induction and measurement of itch. Acta Derm Venereol 1989 69 : 185 9.
12. Ikoma A, Rukwied R, Stander S et al. Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol 2003 139 : 1455 8.
13. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. New York : Mosby, 2007.
14. Valet M, Pfab F, Sprenger T et al. Cerebral processing of histamine-induced itch using short-term alternating temperature modulation - an FMRI study. J Invest Dermatol 2008 128 : 426 33.
15. Yosipovitch G, Greaves MW, McGlone F. Itch: Basic Mechanisms and Therapy, 1st edn. New York : Informa Health Care, 2004.
16. van Os-Medendorp H, Eland-de Kok PC, Ros WJ et al. The nursing programme 'Coping with itch': a promising intervention for patients with chronic pruritic skin diseases. J Clin Nurs 2007 16 : 1238 46.
17. Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep 2008 8 : 306 11.
18. Hosogi M, Schmelz M, Miyachi Y et al. Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain 2006 126 : 16 23.
19. Bender BG, Ballard R, Canono B et al. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008 58 : 415 20.
20. Hon KL, Lam MC, Wong KY et al. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol 2007 157 : 922 5.
21. Weisshaar E, Diepgen TL, Bruckner T et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008 88 : 234 9.
22. Bernhard JD. Itch: Mechanisms and Management of Pruritus. New York : McGraw-Hill, 1994.
23. Reich A, Orda A, Wisnicka B et al. Plasma neuropeptides and perception of pruritus in psoriasis. Acta Derm Venereol 2007 87 : 299 304.
24. Zachariae R, Zachariae CO, Lei U et al. Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008 88 : 121 7.
25. Habif T, Campbell JL, Chapman S et al. Skin Disease: Diagnosis and Treatment. Philadelphia : Elsevier Mosby, 2004.
26. Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis 2007 50 : 11 20.
27. Paye M, Barel AO, Maibach HI. Handbook of Cosmetic Science and Technology, 2nd edn. New York : Taylor & Francis, 2006.
28. Groene D, Martus P, Heyer G. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema. Exp Dermatol 2001 10 : 110 7.
29. Wolverton S. Comprehensive Dermatologic Drug Therapy. Philadelphia : Elsevier-Health Sciences Division, 2007.
30. Physicians' Desk Reference 2008, 62nd edn. Montvale, NJ : Thomson PDR, 2007.